Published in Circulation on June 22, 1999
The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model. J Clin Invest (2002) 2.26
In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament. Circ Res (2011) 1.81
Four independent mutations in the feline fibroblast growth factor 5 gene determine the long-haired phenotype in domestic cats. J Hered (2007) 1.25
Animal models of arrhythmogenic cardiomyopathy. Dis Model Mech (2009) 0.95
Genetic testing in domestic cats. Mol Cell Probes (2012) 0.89
Prevalence of myocardial hypertrophy in a population of asymptomatic Swedish Maine coon cats. Acta Vet Scand (2008) 0.86
Left Ventricular Hypertrophy in Rhesus Macaques (Macaca mulatta) at the California National Primate Research Center (1992-2014). Comp Med (2016) 0.86
MYBPC3's alternate ending: consequences and therapeutic implications of a highly prevalent 25 bp deletion mutation. Pflugers Arch (2013) 0.85
Feline genetics: clinical applications and genetic testing. Top Companion Anim Med (2010) 0.83
Animal and in silico models for the study of sarcomeric cardiomyopathies. Cardiovasc Res (2015) 0.80
Plasma cardiac troponin I concentration and cardiac death in cats with hypertrophic cardiomyopathy. J Vet Intern Med (2014) 0.78
Hypertrophic cardiomyopathy: how do mutations lead to disease? Arq Bras Cardiol (2014) 0.78
Myosin-binding protein C DNA variants in domestic cats (A31P, A74T, R820W) and their association with hypertrophic cardiomyopathy. J Vet Intern Med (2013) 0.78
A Small Molecule Inhibitor of Sarcomere Contractility Acutely Relieves Left Ventricular Outflow Tract Obstruction in Feline Hypertrophic Cardiomyopathy. PLoS One (2016) 0.76
Investigations into the Sarcomeric Protein and Ca(2+)-Regulation Abnormalities Underlying Hypertrophic Cardiomyopathy in Cats (Felix catus). Front Physiol (2017) 0.75
Pharmacodynamic effects of ivabradine, a negative chronotropic agent, in healthy cats. J Vet Cardiol (2011) 0.75
Cardiovascular imaging: what have we learned from animal models? Front Pharmacol (2015) 0.75
Assessment of left ventricular longitudinal function in cats with subclinical hypertrophic cardiomyopathy using tissue Doppler imaging and speckle tracking echocardiography. J Vet Med Sci (2015) 0.75
Echocardiographic assessment of coronary artery flow in normal canines and model dogs with myocardial infarction. J Vet Sci (2013) 0.75
Benazepril and subclinical feline hypertrophic cardiomyopathy: a prospective, blinded, controlled study. Can Vet J (2006) 0.75
End-stage hypertrophic cardiomyopathy in a cat. Can Vet J (2015) 0.75
Hypertrophic cardiomyopathy in young Maine Coon cats caused by the p.A31P cMyBP-C mutation--the clinical significance of having the mutation. Acta Vet Scand (2011) 0.75
Tissue-specific and substrate-specific mitochondrial bioenergetics in feline cardiac and skeletal muscles. J Vet Med Sci (2015) 0.75
Human heart failure with preserved ejection versus feline cardiomyopathy: what can we learn from both veterinary and human medicine? Heart Fail Rev (2017) 0.75
A One Health Approach to Hypertrophic Cardiomyopathy. Yale J Biol Med (2017) 0.75
Protocol for measuring myocardial blood flow by PET/CT in cats. Eur J Nucl Med Mol Imaging (2008) 0.75
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell (1995) 7.73
Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation (2000) 7.50
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature (1998) 7.26
Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation (2000) 5.09
The SQUIRE (Standards for QUality Improvement Reporting Excellence) guidelines for quality improvement reporting: explanation and elaboration. Qual Saf Health Care (2008) 4.59
Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res (1999) 4.57
Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation (1995) 4.48
Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation (2000) 3.99
ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation (1995) 3.79
Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med (1998) 3.41
Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrob Agents Chemother (1995) 3.22
Association of Grb2, Gads, and phospholipase C-gamma 1 with phosphorylated LAT tyrosine residues. Effect of LAT tyrosine mutations on T cell angigen receptor-mediated signaling. J Biol Chem (2000) 3.03
Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J (2002) 3.01
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation (2000) 2.95
Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA (2001) 2.89
The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol (1999) 2.56
Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation (1998) 2.53
Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation (2001) 2.24
Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome. Eur Heart J (2002) 2.17
Human herpes virus 6 in archival cardiac tissues from children with idiopathic dilated cardiomyopathy or congenital heart disease. J Clin Pathol (2008) 2.07
Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest (2000) 1.91
KCNE1 mutations cause jervell and Lange-Nielsen syndrome. Nat Genet (1997) 1.90
Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med (2001) 1.78
Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation (1997) 1.76
Detection of microorganisms in the tracheal aspirates of preterm infants by polymerase chain reaction: association of adenovirus infection with bronchopulmonary dysplasia. Pediatr Res (2000) 1.72
Subacute postictal aggression. Neurology (1998) 1.68
Failure to detect connexin43 mutations in 38 cases of sporadic and familial heterotaxy. Circulation (1996) 1.65
Design and implementation of the North American Pediatric Cardiomyopathy Registry. Am Heart J (2000) 1.65
Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene. Am J Med Genet (1996) 1.65
Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat Genet (1994) 1.55
New mutations in the KVLQT1 potassium channel that cause long-QT syndrome. Circulation (1998) 1.53
Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma. Neurology (1993) 1.52
Atrioventricular bundle degeneration associated with sudden death in the dog. J Am Vet Med Assoc (1978) 1.49
Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II. Circulation (1999) 1.44
Requirement for the SLP-76 adaptor GADS in T cell development. Science (2001) 1.42
Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science (1987) 1.42
The "final common pathway" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy. Herz (2000) 1.42
Closed head injury resulting in paradoxical improvement of a seizure disorder. Seizure (2000) 1.39
Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation (2000) 1.36
Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. Am J Psychiatry (1998) 1.31
Factors affecting strength of perceived foreign accent in a second language. J Acoust Soc Am (1995) 1.29
Genetic and molecular basis of cardiac arrhythmias; impact on clinical management. Study group on molecular basis of arrhythmias of the working group on arrhythmias of the european society of cardiology. Eur Heart J (1999) 1.29
Left-right axis malformations associated with mutations in ACVR2B, the gene for human activin receptor type IIB. Am J Med Genet (1999) 1.27
Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol (1999) 1.25
Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med (1998) 1.20
Viral infection of the myocardium in endocardial fibroelastosis. Molecular evidence for the role of mumps virus as an etiologic agent. Circulation (1997) 1.17
The perception of English and Spanish vowels by native English and Spanish listeners: a multidimensional scaling analysis. J Acoust Soc Am (1995) 1.16
Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol (2001) 1.12
Benign extra-axial collections of infancy. Pediatr Neurosci (1987) 1.11
Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation (1999) 1.11
Echocardiographic assessment of spontaneously occurring feline hypertrophic cardiomyopathy. An animal model of human disease. Circulation (1995) 1.11
Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part III. Circulation (1999) 1.11
Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation (1997) 1.10
Improvement of repolarization abnormalities by a K+ channel opener in the LQT1 form of congenital long-QT syndrome. Circulation (1998) 1.08
Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23. J Clin Invest (1996) 1.06
Interaction of linker for activation of T cells with multiple adapter proteins in platelets activated by the glycoprotein VI-selective ligand, convulxin. J Biol Chem (2000) 1.05
20p12.3 microdeletion predisposes to Wolff-Parkinson-White syndrome with variable neurocognitive deficits. J Med Genet (2008) 1.04
Possible association of the human KCNE1 (minK) gene and QT interval in healthy subjects: evidence from association and linkage analyses in Israeli families. Ann Hum Genet (2005) 1.02
Etiologies of cardiomyopathy and heart failure. Nat Med (1999) 1.02
Acquired cardiac lesions leading to congestive heart failure in the cat. Am J Vet Res (1970) 1.01
Familial ventricular arrhythmias in boxers. J Vet Intern Med (1999) 1.01
Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome. J Am Coll Cardiol (1997) 1.01
Outcome of cardiac transplantation in children. Survival in a contemporary multi-institutional experience. Pediatric Heart Transplant Study. Circulation (1996) 1.01
Primary myocardial disease in the cat. A model for human cardiomyopathy. Am J Pathol (1977) 1.01
Excision and transposition of Tn5 as an SOS activity in Escherichia coli. Genetics (1991) 1.01
Spontaneously occurring arrhythmogenic right ventricular cardiomyopathy in the domestic cat: A new animal model similar to the human disease. Circulation (2000) 1.00
Echocardiographic predictors of adverse clinical events in children with dilated cardiomyopathy: a prospective clinical study. Heart (2004) 1.00
Intrauterine viral infection at the time of second trimester genetic amniocentesis. Obstet Gynecol (1998) 1.00
Genetics, molecular mechanisms and management of long QT syndrome. Ann Med (1998) 1.00
Differentiating anomalous left main coronary artery originating from the pulmonary artery in infants from myocarditis and dilated cardiomyopathy by electrocardiogram. Am J Cardiol (1995) 1.00
Effects of left atrial enlargement on atrial transmembrane potentials and structure in dogs with mitral valve fibrosis. Am J Cardiol (1982) 0.99
FBN2 mutation associated with manifestations of Marfan syndrome and congenital contractural arachnodactyly. J Med Genet (2004) 0.99
The natural clinical history of canine congenital subaortic stenosis. J Vet Intern Med (1995) 0.98
Hypertropic cardiomyopathy and hyperthyroidism in the cat. J Am Vet Med Assoc (1984) 0.98
Cloning and characterization of mPAL, a novel Shc SH2 domain-binding protein expressed in proliferating cells. Oncogene (1999) 0.98
Mechanism of SOS mutagenesis of UV-irradiated DNA: mostly error-free processing of deaminated cytosine. Proc Natl Acad Sci U S A (1992) 0.98
Nonhematopoietic neoplasms in cats. J Natl Cancer Inst (1975) 0.97
Detection of intrauterine viral infection using the polymerase chain reaction. Mol Genet Metab (1998) 0.97
Unusual kinetics of uracil formation in single and double-stranded DNA by deamination of cytosine in cyclobutane pyrimidine dimers. J Mol Biol (1994) 0.97
Effect of donor-recipient size mismatch on left ventricular remodeling after pediatric orthotopic heart transplantation. Am J Cardiol (1995) 0.96
Clinical and pathologic findings in dogs with atherosclerosis: 21 cases (1970-1983). J Am Vet Med Assoc (1986) 0.95
Tumors associated with metallic implants in animals. Clin Orthop Relat Res (1976) 0.94
Genomic scanning for expressed sequences in Xp21 identifies the glycerol kinase gene. Nat Genet (1993) 0.94
Adenovirus infection in the lung results in graft failure after lung transplantation. J Thorac Cardiovasc Surg (1998) 0.94
Current concepts in long QT syndrome. Pediatr Cardiol (2000) 0.94
Restrictive cardiomyopathies in childhood. Etiologies and natural history. Tex Heart Inst J (1997) 0.94
Genomic organization and chromosomal localization of the human Coxsackievirus B-adenovirus receptor gene. Hum Genet (1999) 0.94
Auditory and categorical effects on cross-language vowel perception. J Acoust Soc Am (1994) 0.94
Tumor necrosis factor-alpha in human milk. Pediatr Res (1992) 0.93
The detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV disease. J Am Coll Cardiol (1999) 0.93
Feline intestinal adenocarcinoma. A clinicopathologic study of 22 cases. Vet Pathol (1976) 0.93
Risk factors for burns as a consequence of seizures in persons with epilepsy. Epilepsia (1994) 0.93
A genetic etiology for interruption of the aortic arch type B. Am J Cardiol (1997) 0.93
Clinical implications for affected parents and siblings of probands with long-QT syndrome. Circulation (2001) 0.92
Molecular aspects of myocarditis. Curr Opin Cardiol (1998) 0.92
Clinical and genetic variables associated with acute arousal and nonarousal-related cardiac events among subjects with long QT syndrome. Am J Cardiol (2000) 0.92
Tracheal aspirate as a substrate for polymerase chain reaction detection of viral genome in childhood pneumonia and myocarditis. Circulation (1999) 0.92
Production of the word-final English /t/-/d/ contrast by native speakers of English, Mandarin, and Spanish. J Acoust Soc Am (1992) 0.91
Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndrome. J Med Genet (2006) 0.91